Kemei Diagnostics is a research and development manufacturer of clinical immunochemiluminescence diagnostic reagents and instruments. The products of the company are LiCA series diagnostic reagents based on light-induced chemiluminescence method and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence method, which are mainly used to detect markers of infectious diseases (such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A and hepatitis E), tumor markers, thyroid hormones, reproductive endocrine hormones, myocardial markers and inflammation.
For more peer analysis, enterprises should know about it.